You have no items in your shopping cart.
Laboratory research use only. Not for human or animal consumption.

Metabolic & Body Comp

View as Grid List
Sort by
AOD-9604

AOD-9604

A GH-fragment peptide discussed for fat-metabolism support without the full GH profile.

FatMetabolic
More library details

Research context

  • Reviewed for lipolysis and fat-metabolism signaling.
  • Often compared with broader metabolic medications.

Review before use

  • Track weight, waist, appetite, training, and sleep rather than relying on scale alone.
  • Review realistic expectations and product quality.

Evidence notes

  • Growth-hormone fragment research has explored fat-metabolism signaling with mixed evidence quality.
  • Regulatory status and product quality vary; claims should remain conservative and research-focused.

Cautions

  • Evidence and regulatory status vary by region and product.
  • Avoid replacing proven obesity or metabolic care when clinically needed.

Educational reference only. Not medical advice, dosing guidance, or a treatment claim.

$22.00
5-Amino-1MQ

5-Amino-1MQ

A metabolic research compound discussed around NNMT, energy expenditure, and fat-loss support.

EnergyFat
More library details

Research context

  • Reviewed for NNMT-related metabolic signaling.
  • Often discussed in body-composition and energy-expenditure contexts.

Review before use

  • Clarify legal status, quality, and whether the source is research-only.
  • Track heart rate, sleep, GI response, and mood.

Evidence notes

  • Preclinical research has explored NNMT-related metabolic signaling and body-composition pathways.
  • Human evidence remains limited compared with established metabolic therapies.

Cautions

  • Human evidence and product quality may be limited.
  • Do not use with significant medical conditions without clinician oversight.

Educational reference only. Not medical advice, dosing guidance, or a treatment claim.

$68.00
Semaglutide

Semaglutide

A GLP-1 receptor agonist medication class item commonly reviewed for appetite, satiety, and glucose support.

AppetiteGlucose
More library details

Research context

  • Improves satiety signaling and slows gastric emptying.
  • Supports glucose handling and reduced calorie intake in appropriate patients.

Review before use

  • Review prescription status, escalation plan, GI symptoms, gallbladder risk, and protein intake.
  • Track weight, waist, hydration, bowel habits, and strength training.

Evidence notes

  • GLP-1 receptor agonist medication class with clinical-trial evidence for appetite, glucose, and body-weight outcomes.
  • Research and prescribing use should be separated from research-only product discussion.

Cautions

  • Use only through legitimate medical care.
  • Urgent care is needed for severe abdominal pain, persistent vomiting, or dehydration symptoms.

Educational reference only. Not medical advice, dosing guidance, or a treatment claim.

Call for pricing
Tirzepatide

Tirzepatide

A dual GIP/GLP-1 medication class item reviewed for appetite, weight, and glucose management.

AppetiteWeight
More library details

Research context

  • Acts through incretin pathways that influence satiety and glucose handling.
  • Often produces stronger appetite effects than GLP-1-only approaches for some users.

Review before use

  • Review prescription source, escalation, GI tolerance, and lean-mass preservation plan.
  • Keep protein, resistance training, and constipation prevention visible in the app.

Evidence notes

  • Dual GIP/GLP-1 receptor agonist medication class studied for glucose control, appetite, and body-weight outcomes.
  • Clinical review should include GI tolerance, gallbladder/pancreatitis risk, and lean-mass preservation.

Cautions

  • Medical supervision is required.
  • Discuss pancreatitis, gallbladder, thyroid cancer history, and medication interactions.

Educational reference only. Not medical advice, dosing guidance, or a treatment claim.

Call for pricing
Retatrutide

Retatrutide

A triple receptor agonist research/clinical-trial class item discussed for appetite, body weight, and metabolic effects.

WeightMetabolic
More library details

Research context

  • Targets GLP-1, GIP, and glucagon pathways.
  • Reviewed for strong body-weight and metabolic effects in research contexts.

Review before use

  • Clarify availability, regulatory status, trial data, and medical appropriateness.
  • Track GI tolerance, hydration, weight rate, and strength preservation.

Evidence notes

  • Investigational triple-receptor agonist class item studied for GLP-1, GIP, and glucagon pathway activity.
  • Clinical studies have evaluated effects on body weight, glucose handling, and cardiometabolic markers.

Cautions

  • Not a casual or unsupervised compound.
  • Use legitimate medical channels only.

Educational reference only. Not medical advice, dosing guidance, or a treatment claim.

Call for pricing

FOR RESEARCH USE ONLY. The products offered on this site are intended solely for in-vitro laboratory research and development use. These statements and products have not been evaluated by the U.S. Food and Drug Administration (FDA). These products are not drugs, foods, dietary supplements, or cosmetics, and are not intended to diagnose, treat, cure, or prevent any disease or medical condition. They are not intended for human or animal consumption, ingestion, injection, or any in-vivo or clinical use of any kind. By purchasing from RevPep, you confirm that you are a qualified researcher or institution and that you will handle, store, and dispose of these materials in accordance with all applicable laws, regulations, and institutional safety protocols.